ID24654A - Formulasi farmasi omeprazola - Google Patents
Formulasi farmasi omeprazolaInfo
- Publication number
- ID24654A ID24654A IDW991448A ID991448A ID24654A ID 24654 A ID24654 A ID 24654A ID W991448 A IDW991448 A ID W991448A ID 991448 A ID991448 A ID 991448A ID 24654 A ID24654 A ID 24654A
- Authority
- ID
- Indonesia
- Prior art keywords
- omeprazola
- pharmaceutical formulation
- formulation
- pharmaceutical
- omeprazola pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702000A SE9702000D0 (sv) | 1997-05-28 | 1997-05-28 | New pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ID24654A true ID24654A (id) | 2000-07-27 |
Family
ID=20407122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991448A ID24654A (id) | 1997-05-28 | 1998-05-18 | Formulasi farmasi omeprazola |
Country Status (41)
Country | Link |
---|---|
US (1) | US6090827A (et) |
EP (1) | EP0984773B1 (et) |
JP (1) | JP4649001B2 (et) |
KR (1) | KR100540721B1 (et) |
CN (1) | CN1123338C (et) |
AR (1) | AR012698A1 (et) |
AT (1) | ATE234078T1 (et) |
AU (1) | AU722879B2 (et) |
BR (1) | BR9809484A (et) |
CA (1) | CA2290531C (et) |
CZ (1) | CZ298972B6 (et) |
DE (1) | DE69812089T2 (et) |
DK (1) | DK0984773T3 (et) |
DZ (1) | DZ2494A1 (et) |
EE (1) | EE03903B1 (et) |
EG (1) | EG24044A (et) |
ES (1) | ES2195342T3 (et) |
HK (1) | HK1025744A1 (et) |
HR (1) | HRP980260B1 (et) |
HU (1) | HU229154B1 (et) |
ID (1) | ID24654A (et) |
IL (1) | IL132895A0 (et) |
IS (1) | IS2856B (et) |
MA (1) | MA26497A1 (et) |
MY (1) | MY122298A (et) |
NO (1) | NO328100B1 (et) |
NZ (1) | NZ500886A (et) |
PL (1) | PL194634B1 (et) |
PT (1) | PT984773E (et) |
RS (1) | RS49629B (et) |
RU (1) | RU2207121C2 (et) |
SA (1) | SA98190304B1 (et) |
SE (1) | SE9702000D0 (et) |
SI (1) | SI0984773T1 (et) |
SK (1) | SK286625B6 (et) |
TN (1) | TNSN98068A1 (et) |
TR (1) | TR199902890T2 (et) |
TW (1) | TW575435B (et) |
UA (1) | UA71541C2 (et) |
WO (1) | WO1998053803A1 (et) |
ZA (1) | ZA984178B (et) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6174548B1 (en) * | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
CA2298823C (en) * | 1998-04-20 | 2011-06-07 | Eisai Co., Ltd. | Stabilized composition comprising a benzimidazole type compound |
SE9803772D0 (sv) | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
SE9902386D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
DK1222922T3 (da) | 1999-10-20 | 2007-12-03 | Eisai R&D Man Co Ltd | Fremgangsmåde til stabilisering af benzimidazolforbindelser |
US20040092511A1 (en) * | 1999-12-10 | 2004-05-13 | Billstein Stephan Anthony | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
JP2002234842A (ja) * | 2001-02-09 | 2002-08-23 | Kyowa Yakuhin Kogyo Kk | 内服腸溶性製剤 |
US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
FR2843121B3 (fr) | 2002-08-02 | 2004-09-10 | Rhodia Chimie Sa | Agent ignifugeant, procede de preparation et l'utilisation de cet agent |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040146558A1 (en) * | 2003-01-28 | 2004-07-29 | Kyowa Pharmaceutical Co., Ltd. | Oral enteric-coated preparation |
JP4567340B2 (ja) * | 2003-01-29 | 2010-10-20 | 武田薬品工業株式会社 | 被覆製剤の製造方法 |
NZ541749A (en) | 2003-01-29 | 2009-06-26 | Takeda Pharmaceutical | Process for producing coated preparation comprising pioglitazone hydrochloride and a coating material |
UA86015C2 (ru) * | 2003-01-29 | 2009-03-25 | Такеда Фармасьютикал Компани Лимитед | Способ получения твердой лекарственной формы с покрытием |
EP1603537A4 (en) * | 2003-02-20 | 2009-11-04 | Santarus Inc | IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
CN1311824C (zh) * | 2004-04-21 | 2007-04-25 | 常州市第四制药厂有限公司 | 奥美拉唑肠溶微粒制剂及制备方法 |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1747800B1 (en) * | 2005-07-29 | 2009-03-18 | Rottapharm S.p.A. | Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
KR101436516B1 (ko) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 |
KR101104349B1 (ko) * | 2007-09-28 | 2012-01-16 | 주식회사 씨티씨바이오 | 에소메프라졸 함유 약학 조성물 |
EP2273985B1 (en) * | 2008-03-28 | 2016-02-17 | Ferrer Internacional, S.A. | Capsule for the prevention of cardiovascular diseases |
NZ602496A (en) | 2008-08-19 | 2013-09-27 | Xenoport Inc | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
WO2014031897A1 (en) | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Oral dosage forms having a high loading of (n,n- diethylcarbamoyl)methyl methyl|(2e)but-2-ene-1,4-dioate |
CN102961356A (zh) * | 2012-12-11 | 2013-03-13 | 山西云鹏制药有限公司 | 一种含奥美拉唑的蓝色肠溶片剂的制备方法 |
US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
JP2016534133A (ja) | 2013-09-06 | 2016-11-04 | ゼノポート,インコーポレイティド | (n,n−ジエチルカルバモイル)メチル メチル(2e)ブト−2−エン−1,4−ジオエートの結晶形態、その合成方法及び使用 |
WO2015042294A1 (en) * | 2013-09-18 | 2015-03-26 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
US20230058473A1 (en) | 2020-01-27 | 2023-02-23 | Towa Pharmaceutical Co., Ltd. | Esomeprazole oral preparation and method for producing the same |
KR102432084B1 (ko) | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH05255088A (ja) * | 1991-11-05 | 1993-10-05 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
JP2669446B2 (ja) * | 1992-03-23 | 1997-10-27 | 信越化学工業株式会社 | 医薬品コーティング液用原料粉粒体 |
JPH0733659A (ja) * | 1992-07-17 | 1995-02-03 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
CZ289804B6 (cs) * | 1994-07-08 | 2002-04-17 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma I |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
-
1997
- 1997-05-28 SE SE9702000A patent/SE9702000D0/xx unknown
-
1998
- 1998-05-14 AR ARP980102246A patent/AR012698A1/es not_active Application Discontinuation
- 1998-05-14 HR HR980260A patent/HRP980260B1/xx not_active IP Right Cessation
- 1998-05-15 MA MA25077A patent/MA26497A1/fr unknown
- 1998-05-15 TW TW87107541A patent/TW575435B/zh not_active IP Right Cessation
- 1998-05-18 CA CA002290531A patent/CA2290531C/en not_active Expired - Lifetime
- 1998-05-18 KR KR1019997011083A patent/KR100540721B1/ko not_active IP Right Cessation
- 1998-05-18 IL IL13289598A patent/IL132895A0/xx not_active IP Right Cessation
- 1998-05-18 TR TR1999/02890T patent/TR199902890T2/xx unknown
- 1998-05-18 ID IDW991448A patent/ID24654A/id unknown
- 1998-05-18 DZ DZ980104A patent/DZ2494A1/xx active
- 1998-05-18 AU AU76803/98A patent/AU722879B2/en not_active Ceased
- 1998-05-18 ZA ZA984178A patent/ZA984178B/xx unknown
- 1998-05-18 AT AT98924700T patent/ATE234078T1/de active
- 1998-05-18 DK DK98924700T patent/DK0984773T3/da active
- 1998-05-18 PT PT98924700T patent/PT984773E/pt unknown
- 1998-05-18 ES ES98924700T patent/ES2195342T3/es not_active Expired - Lifetime
- 1998-05-18 EE EEP199900540A patent/EE03903B1/et not_active IP Right Cessation
- 1998-05-18 WO PCT/SE1998/000922 patent/WO1998053803A1/en active IP Right Grant
- 1998-05-18 UA UA99116247A patent/UA71541C2/uk unknown
- 1998-05-18 NZ NZ500886A patent/NZ500886A/en not_active IP Right Cessation
- 1998-05-18 RU RU99126869/14A patent/RU2207121C2/ru not_active IP Right Cessation
- 1998-05-18 DE DE69812089T patent/DE69812089T2/de not_active Expired - Lifetime
- 1998-05-18 CZ CZ0420299A patent/CZ298972B6/cs not_active IP Right Cessation
- 1998-05-18 RS YUP-608/99A patent/RS49629B/sr unknown
- 1998-05-18 SI SI9830433T patent/SI0984773T1/xx unknown
- 1998-05-18 CN CN98805564A patent/CN1123338C/zh not_active Expired - Fee Related
- 1998-05-18 PL PL98337237A patent/PL194634B1/pl unknown
- 1998-05-18 US US09/077,717 patent/US6090827A/en not_active Expired - Lifetime
- 1998-05-18 SK SK1590-99A patent/SK286625B6/sk not_active IP Right Cessation
- 1998-05-18 HU HU0002182A patent/HU229154B1/hu not_active IP Right Cessation
- 1998-05-18 JP JP50056299A patent/JP4649001B2/ja not_active Expired - Fee Related
- 1998-05-18 BR BR9809484-0A patent/BR9809484A/pt not_active Application Discontinuation
- 1998-05-18 EP EP98924700A patent/EP0984773B1/en not_active Expired - Lifetime
- 1998-05-21 TN TNTNSN98068A patent/TNSN98068A1/fr unknown
- 1998-05-25 EG EG56898A patent/EG24044A/xx active
- 1998-05-27 MY MYPI98002355A patent/MY122298A/en unknown
- 1998-07-19 SA SA98190304A patent/SA98190304B1/ar unknown
-
1999
- 1999-11-11 IS IS5245A patent/IS2856B/is unknown
- 1999-11-26 NO NO19995809A patent/NO328100B1/no not_active IP Right Cessation
-
2000
- 2000-08-10 HK HK00105002A patent/HK1025744A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID24654A (id) | Formulasi farmasi omeprazola | |
ID25533A (id) | Formulasi 2-metil-tieno-benzodiazepin | |
DE69525148D1 (de) | Pharmazeutische formulierung | |
NO20012915L (no) | Ny farmasöytisk formulering | |
ID23874A (id) | Obat | |
ID23299A (id) | Formulasi-formulasi farmasi | |
BR9611367A (pt) | Formulação farmacêutic liofilizada estável | |
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
DK1073417T3 (da) | Farmaceutisk aerosolformulering | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
NO980546D0 (no) | Farmasöytiske midler | |
NO981008D0 (no) | Farmasöytisk formulering | |
ID16781A (id) | Formulasi-formulasi farmasi | |
ID29294A (id) | Komposisi farmasi | |
ID30032A (id) | Formulasi farmasi | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
ID25857A (id) | Komposisi farmasi | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
AR025867A1 (es) | Formulacion portasdora farmaceutica | |
ID23531A (id) | Komposisi farmasi | |
SE9600141D0 (sv) | Pharmaceutical formulation | |
SE9803952D0 (sv) | Pharmaceutical formulation | |
FI3862U1 (fi) | Geelimuotoinen farmaseuttinen valmiste | |
BR1100755A (pt) | composição farmacêutica |